Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network

• Main Authors: Ryogo Umetsu (Author), Mizuki Tanaka (Author), Yoko Nakayama (Author), Yamato Kato (Author), Natsumi Ueda (Author), Yuri Nishibata (Author), Shiori Hasegawa (Author), Kiyoka Matsumoto (Author), Noriaki Takeyama (Author), Kazuhiro Iguchi (Author), Hiroyuki Tanaka (Author), Eiichi Hinoi (Author), Naoki Inagaki (Author), Masatoshi Inden (Author), Yoshinori Muto (Author), Mitsuhiro Nakamura (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Montelukast is a selective leukotriene receptor antagonist that is widely used to treat bronchial asthma and nasal allergy. To clarify the association between montelukast and neuropsychiatric adverse events (AEs), we evaluated case reports recorded between January 2004 and December 2018 in the Food...